The HDAC inhibitor carboxycinnamic acid bis-hydroxamide (CBHA), in combination with retinoic acid synergistically suppressed tumor growth using a human neuroblastoma xenograft in vivo [22]. This evidence concerns the gene HDAC9 and neuroblastoma.